---
title: "Abbott India Ltd (ABBOTINDIA) — Share Price, Financials & Analysis"
symbol: "ABBOTINDIA"
company: "Abbott India Ltd"
canonical: "https://tapetide.com/stocks/ABBOTINDIA"
isin: "INE358A01014"
nse_symbol: "ABBOTINDIA"
bse_code: "500488"
sector: "Healthcare"
industry: "Pharmaceuticals"
market_cap_cr: 53537.62
generated_at: "2026-09-13T18:47:53.345Z"
---

# Abbott India Ltd (ABBOTINDIA)

Canonical page: https://tapetide.com/stocks/ABBOTINDIA

## Company

- **NSE Symbol:** ABBOTINDIA
- **BSE Code:** 500488
- **ISIN:** INE358A01014
- **Sector:** Healthcare
- **Industry:** Pharmaceuticals
- **Macro Sector:** Healthcare
- **Stock Type:** EQUITY
- **Listed Since:** 2010-01-08
- **CEO:** Mr. Kartik Rajendran
- **Employees:** 3659
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** abbott.co.in

## About

Abbott India Ltd is one of the leading multinational pharmaceutical companies in India and sells its products through independent distributors primarily within India.[1] It was established in 1944.[2]

## Latest Price

- **Price:** ₹25550
- **Change:** +290 (+1.15%)
- **Open:** ₹25260
- **Day High:** ₹25635
- **Day Low:** ₹25135
- **Previous Close:** ₹25260
- **Volume:** 9615
- **As Of:** 2026-09-11T10:23:07+00:00

## Key Fundamentals

Observed at 2026-09-11T04:37:33.636746Z.

- **Market Cap:** ₹53537.62 Cr
- **Classification:** Midcap
- **P/E (reported):** 33.3
- **P/E (TTM):** 33.62
- **EPS (TTM):** ₹759.88
- **EPS (reported):** ₹583.05
- **Book Value:** ₹2246.68
- **Price to Book:** 11.25
- **Dividend Yield:** 2.6%
- **ROE:** 32.51%
- **ROCE:** 41.87%
- **Debt to Equity:** 0.04
- **Revenue (yearly):** ₹7217.2 Cr
- **Net Income:** ₹1552 Cr
- **EBITDA:** ₹2180.2 Cr
- **52-Week High:** ₹31495
- **52-Week Low:** ₹25150
- **RSI (14):** 29.36

## Tapetide Score

- **Score:** 54 / 100
- **Score date:** 2026-09-04
- **Archetype:** Out of Favour
- **What it means:** Financially sound, yet the market is not rewarding it. Cases like this usually need a specific reason the pessimism is misplaced, and patience for that reason to play out.
- **Pillar profile:** Quality: Good · Valuation: Cheap · Momentum: Falling
- **Percentile:** 65.6 (of 4473 scored stocks)
- **Confidence:** 100%
- **Data coverage:** 100%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 86.03 | 9% |
| growth | 14.31 | 9% |
| momentum | 13.06 | 12% |
| ownership | 47.69 | 24% |
| quality | 71.61 | 22% |
| valuation | 67.12 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Strengths

- Company is almost debt free.
- Company has a good return on equity (ROE) track record: 3 Years ROE 34.9%
- Company has been maintaining a healthy dividend payout of 77.9%

### Weaknesses

- Stock is trading at 11.4 times its book value
- The company has delivered a poor sales growth of 9.96% over past five years.

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | 30.38% | 8.78% | 39.21% |
| ebitda margin growth | 7.46% | 2.51% | 8.28% | 29.55% |
| net income growth | 8.51% | 9.73% | 18% | 17% |
| revenue growth | 5.83% | 7.97% | 9% | 10% |
| roce | — | -0.52% | -1.09% | 40.23% |
| roe | — | -2.69% | 32.8% | 14.8% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 1494 | 1437 | 1439 | 1558 | 1633 | 1614 | 1605 | 1738 | 1757 | 1724 | 1710 | 1814 |
| Expenses | 1113 | 1049 | 1109 | 1167 | 1194 | 1178 | 1176 | 1293 | 1255 | 1261 | 1229 | 1291 |
| Operating Profit | 381 | 388 | 330 | 391 | 439 | 436 | 429 | 446 | 502 | 463 | 481 | 522 |
| OPM % | 25 | 27 | 23 | 25 | 27 | 27 | 27 | 26 | 29 | 27 | 28 | 29 |
| Other Income | 56 | 56 | 81 | 67 | 60 | 72 | 76 | 73 | 70 | 70 | 76 | 75 |
| Interest | 3 | 3 | 3 | 3 | 2 | 2 | 4 | 6 | 8 | 5 | 6 | 6 |
| Depreciation | 18 | 18 | 18 | 18 | 18 | 18 | 18 | 19 | 19 | 19 | 19 | 20 |
| Profit before tax | 415 | 422 | 390 | 437 | 479 | 488 | 483 | 493 | 546 | 509 | 531 | 572 |
| Tax % | 25 | 26 | 26 | 25 | 25 | 26 | 24 | 26 | 24 | 26 | 26 | 25 |
| Net Profit | 313 | 311 | 287 | 328 | 359 | 361 | 367 | 366 | 415 | 376 | 395 | 429 |
| EPS in Rs | 147.27 | 146.35 | 135.09 | 154.36 | 168.76 | 169.78 | 172.73 | 172.18 | 195.43 | 176.93 | 185.86 | 201.66 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 3298 | 3679 | 4093 | 4310 | 4919 | 5349 | 5849 | 6409 | 6929 | 7004 |
| Expenses | 2774 | 3074 | 3336 | 3388 | 3832 | 4143 | 4396 | 4714 | 5037 | 5035 |
| Operating Profit | 525 | 605 | 757 | 922 | 1088 | 1206 | 1453 | 1695 | 1892 | 1969 |
| OPM % | 16 | 16 | 18 | 21 | 22 | 23 | 25 | 26 | 27 | 28 |
| Other Income | 117 | 113 | 114 | 81 | 77 | 154 | 248 | 275 | 288 | 291 |
| Interest | 4 | 2 | 9 | 18 | 19 | 16 | 12 | 11 | 25 | 25 |
| Depreciation | 16 | 17 | 60 | 58 | 66 | 70 | 71 | 72 | 76 | 76 |
| Profit before tax | 621 | 699 | 803 | 926 | 1080 | 1274 | 1618 | 1887 | 2079 | 2158 |
| Tax % | 35 | 36 | 26 | 25 | 26 | 25 | 26 | 25 | 25 | — |
| Net Profit | 401 | 450 | 593 | 691 | 799 | 949 | 1201 | 1414 | 1552 | 1615 |
| EPS in Rs | 188.82 | 211.93 | 279.04 | 325.04 | 375.87 | 446.8 | 565.3 | 665.64 | 730.39 | 759.88 |
| Dividend Payout % | 29 | 31 | 90 | 85 | 73 | 73 | 73 | 71 | 90 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 21 | 21 | 21 | 21 | 21 | 21 | 21 | 21 | 21 | 21 |
| Reserves | 1366 | 1672 | 1987 | 2410 | 2581 | 2799 | 3167 | 3678 | 4212 | 4753 |
| Borrowings | 0 | 0 | 0 | 175 | 153 | 152 | 113 | 83 | 197 | 172 |
| Other Liabilities | 679 | 723 | 932 | 940 | 1086 | 1253 | 1254 | 1411 | 1487 | 1556 |
| Total Liabilities | 2066 | 2416 | 2941 | 3547 | 3840 | 4224 | 4556 | 5193 | 5917 | 6502 |
| Fixed Assets | 110 | 81 | 105 | 270 | 251 | 271 | 237 | 225 | 336 | 331 |
| CWIP | 6 | 2 | 1 | 2 | 1 | 1 | 4 | 10 | 18 | 6 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 1950 | 2333 | 2835 | 3275 | 3589 | 3952 | 4315 | 4958 | 5563 | 6165 |
| Total Assets | 2066 | 2416 | 2941 | 3547 | 3840 | 4224 | 4556 | 5193 | 5917 | 6502 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 307 | 153 | 499 | 626 | 727 | 948 | 893 | 1213 | 1012 | 1319 |
| Cash from Investing Activity | -155 | -215 | -257 | -401 | -72 | -396 | -148 | -416 | 182 | -371 |
| Cash from Financing Activity | -90 | -102 | -143 | -217 | -582 | -637 | -639 | -745 | -925 | -1066 |
| Net Cash Flow | 62 | -165 | 99 | 8 | 73 | -86 | 107 | 52 | 269 | -118 |
| Free Cash Flow | 287 | 180 | 504 | 611 | 704 | 904 | 860 | 1165 | 960 | 1307 |
| CFO/OP | 117 | 68 | 125 | 113 | 104 | 114 | 102 | 111 | 86 | 98 |

### Ratios

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 22 | 29 | 27 | 28 | 21 | 21 | 22 | 20 | 22 | 19 |
| Inventory Days | 107 | 112 | 106 | 83 | 110 | 94 | 80 | 70 | 92 | 94 |
| Days Payable | 101 | 92 | 116 | 104 | 116 | 122 | 109 | 114 | 110 | 109 |
| Cash Conversion Cycle | 28 | 49 | 17 | 8 | 14 | -6 | -8 | -24 | 3 | 3 |
| Working Capital Days | 21 | 63 | 22 | 10 | 4 | -7 | -8 | -14 | 99 | 2 |
| ROCE % | 34 | 41 | 37 | 35 | 35 | 38 | 41 | 46 | 46 | 45 |

## Shareholding Pattern

### Quarterly

| Category | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 74.99% | 74.99% | 74.99% | 74.99% | 74.99% | 74.99% | 74.99% | 74.99% | 74.99% | 74.99% | 74.99% | 74.99% |
| FIIs | 0% | 0.18% | 0.18% | 0.18% | 0.16% | 0.16% | 0.16% | 0.16% | 0.16% | 0.18% | 0.26% | 0.38% |
| DIIs | 8.71% | 8.74% | 8.91% | 8.81% | 8.99% | 9.01% | 8.92% | 9.19% | 9.11% | 9% | 8.93% | 8.78% |
| Government | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 13.89% | 13.97% | 13.8% | 13.86% | 13.65% | 13.59% | 13.66% | 13.35% | 13.43% | 13.42% | 13.38% | 13.41% |
| Others | 2.42% | 2.13% | 2.12% | 2.16% | 2.21% | 2.25% | 2.28% | 2.31% | 2.31% | 2.42% | 2.43% | 2.44% |
| No. of Shareholders | 68885 | 72252 | 69382 | 71588 | 69449 | 67892 | 69934 | 67584 | 71199 | 75801 | 75866 | 78320 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Sell
- **Buy / Neutral / Sell:** 2 / 5 / 12

### Moving Averages — summary: **Strong Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 25757 | Sell |
| EMA (10) | 25741.38 | Sell |
| SMA (20) | 26086.25 | Sell |
| EMA (20) | 26116.93 | Sell |
| SMA (50) | 27059.9 | Sell |
| EMA (50) | 26585.39 | Sell |
| SMA (100) | 26705.1 | Sell |
| EMA (100) | 26791.61 | Sell |
| SMA (200) | 27050.65 | Sell |
| EMA (200) | 27384.35 | Sell |

### Oscillators — summary: **Neutral**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 36.29 | Neutral |
| MACD (12,26,9) | -456.33 | Sell |
| Stochastic (14,3,3) | 10.84 | Buy |
| ADX (14) | 25.13 | Buy |
| Williams %R (14) | -74.22 | Neutral |
| ATR (14) | 462.45 | Neutral |
| ROC (12) | -3.78 | Sell |
| Stoch RSI (14) | 63.21 | Neutral |
| UO (7,14,28) | 35.73 | Neutral |

## Analyst Ratings

| Recommendation | Analysts | Share |
| --- | --- | --- |
| Buy | 6 | 85.71% |
| Hold | 1 | 14.29% |
| Sell | 0 | 0% |

Based on 7 analyst ratings, observed at 2026-09-11T04:37:31.830319+00:00.

## Filings & Documents

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-09-07 | [Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=157bb825-598b-46e3-9f28-329f6c486311.pdf) |
| 2026-08-14 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a564dbbb-ad34-4f3c-92e7-15ca8baa30d4.pdf) |
| 2026-08-14 | [Shareholder Meeting / Postal Ballot-Scrutinizers Report](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0499f3bb-9238-4958-9689-bae314e3d417.pdf) |
| 2026-08-13 | [Shareholder Meeting / Postal Ballot-Outcome of AGM](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c1f745a6-4c9c-4159-a7f1-bf5f48b2b6cb.pdf) |
| 2026-08-12 | [Board Meeting Outcome for Outcome Of Board Meeting](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=14ff8eca-4382-41a6-9f02-d40caa169b4e.pdf) |
| 2026-08-04 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=40364250-2c93-4e40-a2d6-a58c61281182.pdf) |
| 2026-08-04 | [Board Meeting Intimation for Considering And Approving The Unaudited Financial Results Of The Company For The Quarter Ended June 30 2026.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0130cc06-8d28-4b92-81b1-02a45c7b92a0.pdf) |
| 2026-07-20 | [Reg. 34 (1) Annual Report.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3c9b421d-7c7d-4d5b-b706-804fec5dd31e.pdf) |
| 2026-07-20 | [Annual General Meeting On August 13 2026.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7eef9ec4-a190-4347-bc09-ef917a707e11.pdf) |
| 2026-07-20 | [Business Responsibility and Sustainability Reporting (BRSR)](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b43190be-4346-4363-8154-007034b9bcbb.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-08-12 | [Unaudited Financial Results For The Quarter Ended June 30 2026.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=998149c4-3720-41f2-bd67-55fe03bf59c6.pdf) |
| 2026-05-11 | [Audited Financial Results For The Quarter And Year Ended March 31 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5ace319e-d492-46a0-aea1-003d086a6541.pdf) |
| 2026-02-12 | [Unaudited Financial Results Of The Company For The Quarter Ended December 31 2025.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=580fb90c-b714-4e84-8cd6-d07dcd6ddcf6.pdf) |
| 2025-11-06 | [Unaudited Financial Results For The Quarter Ended September 30 2025.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=54186b0c-acef-45e7-8ca4-7bbd1ecae0ae.pdf) |
| 2025-08-12 | [Board Meeting Outcome for Outcome Of Board Meeting](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=169a7fa4-35a3-4031-8c5c-8c9496db16e8.pdf) |
| 2025-08-12 | [Unaudited Financial Results For The Quarter Ended June 30 2025.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e2697b15-bbc8-45e5-beac-f470b7dc0a66.pdf) |
| 2025-05-15 | [Results For The Financial Year Ended March 31 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7d242426-6c1f-4aff-a096-6e083c6c3f4f.pdf) |
| 2025-02-05 | [Unaudited Financial Results For The Quarter And Nine Months Ended December 31 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ae901a61-4364-4b2e-9fc4-0b119dbc61a3.pdf) |
| 2024-11-07 | [Unaudited Financial Results For The Quarter And Half Year Ended September 30, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9e78f1fc-f839-4656-b53a-15e7e5e2e021.pdf) |
| 2024-08-07 | [Unaudited Financial Results Of The Company For The First Quarter Ended On June 30, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b0b208f2-8f32-452d-a55f-dc2db8f13136.pdf) |

### Other Documents

| Date | Document |
| --- | --- |
| 8 Apr - Regulation 74(5) certificate filed for quarter ended March 31, 2026. | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 8 Apr - Regulation 74(5) certificate filed for quarter ended March 31, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/262e423c-f99d-47a1-b55c-6a791fb01b57.pdf) |
| 5h - FY26 audited results approved; final dividend Rs525 and special dividend Rs131 per share, record date July 24. | [Board Meeting Outcome for Outcome Of Board Meeting 5h - FY26 audited results approved; final dividend Rs525 and special dividend Rs131 per share, record date July 24.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/9db95d92-dd76-4f39-9805-6aa5fbf56e08.pdf) |
| 30 Apr - Board meets May 11, 2026 to approve FY26 audited results, financial statements, and final dividend. | [Board Meeting Intimation for Considering Audited Financial Results Of The Company For The Quarter And Financial Year Ended March 31, 2026, Along With The Audit Report Of The Statutory Auditors Thereon And To Recommend Final Dividend For The Financial Year Ended March 31, 2026. 30 Apr - Board meets May 11, 2026 to approve FY26 audited results, financial statements, and final dividend.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/615d7005-95e6-4c57-a603-c9fd4f80e416.pdf) |
| 30 Apr - Board meets May 11, 2026 to approve FY26 audited results, financial statements, and final dividend. | [Board Meeting Intimation for Considering Audited Financial Results Of The Company For The Quarter And Financial Year Ended March 31, 2026, Along With The Audit Report Of The Statutory Auditors Thereon And To Recommend Final Dividend For The Financial Year Ended March 31, 2026. 30 Apr - Board meets May 11, 2026 to approve FY26 audited results, financial statements, and final dividend.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/615d7005-95e6-4c57-a603-c9fd4f80e416.pdf) |
| 30 Apr - Abbott India says it was not a large corporate as of March 31, 2026; outstanding borrowing nil. | [Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A 30 Apr - Abbott India says it was not a large corporate as of March 31, 2026; outstanding borrowing nil.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/7e2f5bfe-f0c2-411f-884a-e7d7a4e37892.pdf) |
| 30 Apr - Abbott India says it was not a large corporate as of March 31, 2026; outstanding borrowing nil. | [Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A 30 Apr - Abbott India says it was not a large corporate as of March 31, 2026; outstanding borrowing nil.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/7e2f5bfe-f0c2-411f-884a-e7d7a4e37892.pdf) |
| 3 Apr - Newspaper Advertisement - Special Window for Transfer and Dematerialisation of Physical Securities. | [Announcement under Regulation 30 (LODR)-Newspaper Publication 3 Apr - Newspaper Advertisement - Special Window for Transfer and Dematerialisation of Physical Securities.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/129c94ab-8305-4095-b687-ef31aaf4384d.pdf) |
| 27 Feb - Abbott to commercialize Novo Nordisk’s semaglutide (Extensior/Ozempic) in India; announced Feb 27, 2026. | [Announcement under Regulation 30 (LODR)-Press Release / Media Release 27 Feb - Abbott to commercialize Novo Nordisk’s semaglutide (Extensior/Ozempic) in India; announced Feb 27, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/1c3ccf33-0293-414a-a0f2-81dcfd9340bd.pdf) |
| 22 Apr - Abbott India announces board changes, one resignation, two director appointments, and Goa plant leadership transition. | [Board Meeting Outcome for Outcome Of Board Meeting 22 Apr - Abbott India announces board changes, one resignation, two director appointments, and Goa plant leadership transition.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/a1079342-dc96-46c7-ba1d-504dd8594c4a.pdf) |
| 22 Apr - Abbott India announced board changes, two director appointments, one resignation, and Goa plant leadership transition. | [Announcement under Regulation 30 (LODR)-Change in Management 22 Apr - Abbott India announced board changes, two director appointments, one resignation, and Goa plant leadership transition.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/99ddfeb7-c280-47a7-964e-b4068224243d.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from nse | [Financial Year 2013 from nse](https://archives.nseindia.com/annual_reports/AR_2108_SIRPAPER_2012_2013_27092013113735.zip) |
| from nse | [Financial Year 2010 from nse](https://archives.nseindia.com/annual_reports/AR_SIRPAPER_2009_2010_20092010120000.zip) |
| from bse | [Annual Report 2026 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/3c9b421d-7c7d-4d5b-b706-804fec5dd31e.pdf) |
| from bse | [Annual Report 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/c3fb8f23-0192-4f2d-a6a5-022e6dd553fb.pdf) |
| from bse | [Annual Report 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/270738a5-1a37-4f0f-9de6-e16dc27ff432.pdf) |
| from bse | [Annual Report 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/68827cf7-67af-4209-91f5-3854d3e1e8a2.pdf) |
| from bse | [Annual Report 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/500488/73779500488.pdf) |
| from bse | [Annual Report 2021 from bse](https://www.bseindia.com/bseplus/AnnualReport/500488/68744500488.pdf) |
| from bse | [Annual Report 2020 from bse](https://www.bseindia.com/bseplus/AnnualReport/500488/5004880320.pdf) |
| from bse | [Annual Report 2019 from bse](https://www.bseindia.com/bseplus/AnnualReport/500488/5004880319.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T18:47:53.345Z.